Abstract
The prevalence of antibodies against HIV-1 regulatory proteins in sera of HIV-infected patients from different stages of disease was investigated. HIV-1 vif, tat, and nef genes were cloned in procaryotic vectors and were expressed as MS-2 fusion proteins (vif and nef) or as a non-fusion protein (tat). These recombinant proteins were employed in immunoblot experiments. The specifity of the recognition was confirmed by competition experiments and with control sera from HIV-negative patients. Analysis of 136 serum samples revealed a high percentage of antibodies against nef, irrespective of the stage of disease. Antibodies against tat were found less frequently and increased from 16% to 40% with disease progression. Vif antibodies were detected only in a low percentage in early stages of disease, but their prevalence increased to 36% and 72% with progression of disease to AIDS-related complex and AIDS. Our data suggest that the detection of antibodies against nef may represent an additional and useful marker for the diagnosis of HIV infection, whereas the detection of vif antibodies may indicate disease progression.
Similar content being viewed by others
References
Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA (1986) Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 59:284–291
Aldovini A, Debouck C, Feinberg MB, Rosenberg M, Arya SK, Wong-Staal F (1986) Synthesis of the complete trans-activation gene product of human T lymphotropic virus type III in Escherichia coli: demonstration of immunogenicity in vivo and expression in vitro. Proc Natl Acad Sci USA 83:6672–6676
Allan JS, Coligan JE, Lee TH, McLane MF, Kanki PJ, Groopman JE, Essex M (1985) A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients. Science 230:810–813
Ameisen JC, Guy B, Lecocq JP, Chamaret S, Montagnier L, Loche M, Mach B, Tartar A, Mouton Y, Capron A (1989a) Persistent antibody response to the HIV-1 negative regulatory factor in HIV-linfected seronegative persons. N Engl J Med 320:251–252
Ameisen JC, Guy B, Chamaret S, Loche M, Mouton Y, Neyrinck JL, Khalife J, Leprevost C, Beaucaire G, Boutillon C, Gras-Masse H, Maniez M, Kiény MP, Laustriat D, Berthier A, Mach B, Montagnier L, Lecocq JP, Capron A (1989b) Antibodies to the nef protein and to nef peptides in HIV-1-infected sero-negative individuals. AIDS Res Hum Retroviruses 5:279–291
Arya SK (1987) 3′ orf and sor genes of human immunodeficiency virus: in vitro transcriptiontranslation and immunoreactive domains. Proc Natl Acad Sci USA 84:5429–5433
Arya SK, Gallo RC (1986) Three novel genes of human T lymphotropic virus type III: immune reactivity of their products with sera from acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 83:2209–2213
Arya SK, Guo C, Josephs SF, Wong-Staal F (1985) Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). Science 229:69–73
Barone AK, Silva JJ, Ho DD, Gallo RC, Wong-Staal F, Chang NT (1986) Reactivity of E. coli derived transactivating protein of human T lymphotropic virus type III with sera from patients with acquired immune deficinecy syndrome. J Immunol 137:669–673
Franchini G, Robert-Guroff M, Wong-Staal F, Ghrayeb J, Kato I, Chang TW, Chang NT (1986) Expression of the protein encoded by the 3′ open reading frame of human T cell lymphotropic virus type III in bacteria: demonstration of its immunoreactivity with human sera. Proc Natl Acad Sci USA 83:5282–5285
Franchini G, Robert-Guroff M, Aldovini A, Kan NC, Wong-Staal F (1987) Spectrum of natural antibodies against five HTLV-III-antigens in infected individuals: correlation of antibody prevalence with clinical status. Blood 69:437–441
Gombert FO, Blecha W, Tähtinen M, Ranki A, Pfeiffer S, Tröger W, Braun R, Müller-Lantzsch N, Jung G, Rübsamen-Waigmann H, Krohn K (1990) Antigenic epitopes of nef proteins from different HIV-1 strains as recognized by sera from patients with manifest and latent HIV-infection Virology (in press)
Guesdon JL, Ternynck T, Avrameas S (1979) The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem 27:1131–1139
Hess J, Stemler M, Will H, Schröder CH, Kühn J, Braun R (1988) Frequent detection of antibodies to hepatitis B virus x-protein in acute, chronic and resolved infections. Med Microbiol Immunol 177:195–205
Kan NC, Franchini G, Wong-Staal F, DuBois GC, Robey WG, Lautenberger JA, Papas TS (1986) Identification of HTLV-III/LAV sor gene product and detection of antibodies in human sera. Science 231:1553–1555
Klinkert MQ, Ruppel A, Felleisen R, Link G, Beck E (1988) Expression of diagnostic 31/32 kilodalton proteins of Schistosoma mansoni as fusions with bacteriophage MS2 polymerase. Mol Biochem Parasitol 27:233–240
Krone WJA; Debouck C, Epstein LG, Heutink P, Meloen R, Goudsmit J (1988) Natural antibodies to HIV-tat epitopes and expression of HIV-1 genes in vivo. J Med Virol 26:261–270
Kühn JE, Dunkler G, Munk K, Braun RW (1987) Analysis of IgM and IgG antibody response against herpes simplex virus type 1 (HSV-1) structural and nonstructural proteins. J Med Virol 23:135–150
Kühn JE, Eing BR, Brossmer R, Munk K, Braun RW (1988a) Removal of N-linked carbohydrates decreases the infectivity of herpes simplex virus type 1. J Gen Virol 69:2847–2858
Kühn JE, Dunkler G, Munk K, Braun RW (1988b) The use of Western blot procedures in the analysis of herpes simplex proteins. In:Pal SB (ed) Reviews on immunoassay technology. MacMillan Press, London, pp 177–194
Küpper H, Delamarter J, Otto B, Schaller H (1982) Expression of major foot and mouth disease antigen in E. coli In:Ikeda Y, Beppu T (eds) Proceedings of the IVth International Symposium on Genetics of Industrial Microorganisms. Kodansha, Tokyo, pp 222–226
Lee TH, Coligan JE, Allan JS, McLane MF, Groopman JE, Essex M (1986) A new HTLV-III/LAV protein encoded by a gene found in cytopathic retroviruses. Science 231:1546–1549
McPhee DA, Kemp BE, Cumming S, Stapleton D, Gust ID, Doherty RR (1988) Recognition of envelope and tat protein synthetic peptide analogs by HIV positive sera or plasma. FEBS Lett 233:393–396
Neuhoff V, Stamm R, Eibl H (1985) Clear background and highly sensitive protein staining with Coomassie blue dyes in polyacrylamide gels: a systematic analysis. Electrophoresis 6:427–448
Ranki A, Krohn M, Allain JP, Franchini G, Valle SL, Antonen J, Leuther M, Krohn K (1987) Long latency precedes overt seroconversion in sexually transmitted human immunodeficiency virus infection. Lancet 11:589–593
Remaut E, Stanssens P, Fiers W (1981) Plasmid vectors for high-efficiency expression controlled by the pl promoter of coliphage lambda. Gene 15:81–93
Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463–5467
Sodroski J, Goh WC, Rosen C, Tartar A, Portetelle D, Burny A, Haseltine W (1986) Replicative and cytopathic potential of HTLV-III/LAV with sor gene deletions. Science 231:1549–1553
Strebel K, Beck E, Strohmeier K, Schaller H (1986) Characterization of foot-and-mouth disease virus gene products with antisera against bacterially synthesized fusion proteins. J Virol 57:983–991
Thomas JO, Kornberg RD (1975) An octamer of histones in chromatin and free in solution. Proc Natl Acad Sci USA 72:2626–2630
Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350–4353
Tucker J, Szakiel G, Feuerstein J, John J, Goody RS, Wittinghofer A (1986) Expression of p21 proteins in Escherichia coli and stereochemistry of the nucleotide binding site. EMBO J 5:1351–1358
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wieland, U., Kühn, J.E., Jassoy, C. et al. Antibodies to recombinant HIV-1 vif, tat, and nef proteins in human sera. Med Microbiol Immunol 179, 1–11 (1990). https://doi.org/10.1007/BF00190145
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00190145